Idea Of Government Withholding Protections For High-Priced Drugs Surfaces Again

Congress should consider taking away government protections meant to encourage drug development when drug companies charge prices that the government determines excessive, Institute for Clinical and Economic Review President Steven Pearson suggested at a briefing last week. Those seeking to curb drug price increases have started mentioning that basic approach more often in recent months, and Pearson said the government could also reward pharmaceutical makers who keep the prices of their drugs down by removing such restrictions as copays and...